ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 247 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2016. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $2,308,000 | -19.9% | 180,900 | -35.9% | 0.08% | -22.2% |
Q4 2016 | $2,880,000 | +1258.5% | 282,100 | +1652.2% | 0.10% | +2375.0% |
Q3 2016 | $212,000 | -83.0% | 16,100 | -83.6% | 0.00% | -90.5% |
Q2 2016 | $1,247,000 | -76.0% | 98,200 | -75.0% | 0.04% | -72.5% |
Q1 2016 | $5,198,000 | -6.8% | 393,500 | +8.5% | 0.15% | +10.1% |
Q4 2015 | $5,578,000 | +4001.5% | 362,700 | +3197.3% | 0.14% | +2680.0% |
Q3 2015 | $136,000 | -96.7% | 11,000 | -96.3% | 0.01% | -95.2% |
Q2 2015 | $4,093,000 | +13.6% | 299,200 | -0.7% | 0.10% | +5.0% |
Q1 2015 | $3,604,000 | +2335.1% | 301,300 | +2497.4% | 0.10% | +1900.0% |
Q4 2014 | $148,000 | -91.2% | 11,600 | -90.7% | 0.01% | -92.1% |
Q3 2014 | $1,677,000 | -30.7% | 125,000 | -17.1% | 0.06% | -42.7% |
Q2 2014 | $2,419,000 | +66.0% | 150,700 | +53.8% | 0.11% | -16.7% |
Q3 2013 | $1,457,000 | +654.9% | 98,000 | +557.7% | 0.13% | +560.0% |
Q2 2013 | $193,000 | – | 14,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |